{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:44:51Z","timestamp":1767624291992,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clindermatol.2021.12.012","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:00:26Z","timestamp":1641034826000},"page":"516-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Annular bullous diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Morgan","family":"Sussman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Morquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.12.012_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40257-016-0202-8","article-title":"subcorneal pustular dermatosis: a review of 30 years of progress","volume":"17","author":"Watts","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin Dermatol"},{"year":"2016","series-title":"Autoimmune Bullous Diseases","author":"Sami","key":"10.1016\/j.clindermatol.2021.12.012_bib0004"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","volume":"94","author":"Miyamoto","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0006","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0007","first-page":"1","article-title":"Association between HLA-DQB1*03:01 and bullous pemphigoid in Iranian patients","volume":"10","author":"Esmaili","year":"2013","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0008","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1346-8138.2000.tb02141.x","article-title":"Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid","volume":"27","author":"Okazaki","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0009","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0010","doi-asserted-by":"crossref","first-page":"adv00224","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0013","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1590\/S1807-59322009001100002","article-title":"Pemphigoid gestationis: clinical and laboratory evaluation","volume":"64","author":"Cobo","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0014","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.jid.5700594","article-title":"The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies","volume":"127","author":"Di Zenzo","year":"2007","journal-title":"J Invest Dermatol"},{"year":"2006","series-title":"Lookingbill and Marks\u2019 Principles of Dermatology","author":"Marks","key":"10.1016\/j.clindermatol.2021.12.012_bib0015"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0016","article-title":"Recognizing presentations of pemphigoid gestationis: a case study","volume":"2014","author":"Henry","year":"2014","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0017","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0018","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-4632.2008.03473.x","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"47","author":"Feng","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archderm.143.9.1168","article-title":"Herpes gestationis in a mother and newborn: immunoclinical perspectives based on a weekly follow-up of the enzyme-linked immunosorbent assay index of a bullous pemphigoid antigen noncollagenous domain","volume":"143","author":"Aoyama","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0021","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/0019-5154.74534","article-title":"Salt split technique: a useful tool in the diagnosis of subepidermal bullous disorders","volume":"55","author":"De","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0022","first-page":"72","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clindermatol.2011.03.009","article-title":"Pemphigoid gestationis","volume":"30","author":"Lipozen\u010di\u0107","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1346-8138.2003.tb00353.x","article-title":"Treatment of bullous pemphigoid","volume":"30","author":"Fontaine","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2133.2000.03358.x","article-title":"The clinical spectrum of epidermolysis bullosa simplex","volume":"142","author":"Horn","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0026","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-4632.2011.05102.x","article-title":"Epidermolysis bullosa simplex, Dowling-Meara type with eruptive nevi","volume":"51","author":"Lattouf","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0625.2011.01420.x","article-title":"Gene expression analysis of an epidermolysis bullosa simplex Dowling-Meara cell line by subtractive hybridization: recapitulation of cellular differentiation, migration and wound healing","volume":"21","author":"Wagner","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S0365-05962013000200001","article-title":"Inherited epidermolysis bullosa: clinical and therapeutic aspects","volume":"88","author":"Boeira","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaad.2007.02.023","article-title":"Dyskeratosis as a histologic feature in epidermolysis bullosa simplex-Dowling Meara","volume":"57","author":"Bergman","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","article-title":"Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases","volume":"11","author":"Montaudi\u00e9","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0031","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0032","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0033","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/DAD.0000000000001313","article-title":"Linear IgA bullous dermatosis preceding the diagnosis of primary sclerosing cholangitis and ulcerative colitis: a case report","volume":"41","author":"Humphrey","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0034","doi-asserted-by":"crossref","first-page":"omz004","DOI":"10.1093\/omcr\/omz004","article-title":"Bullous dermatosis suspected in an 8-month-old child in Guinea-Bissau","volume":"2019","author":"Valle Del Barrio","year":"2019","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ccr3.2039","article-title":"Vancomycin-induced linear IgA bullous dermatosis (LABD)-an atypical presentation","volume":"7","author":"Visentainer","year":"2019","journal-title":"Clin Case Rep"},{"year":"2020","series-title":"LinearIGA Dermatosis","author":"Bernett","key":"10.1016\/j.clindermatol.2021.12.012_bib0036"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0037","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ad.2018.06.017","article-title":"Linear IgA bullous dermatosis: a series of 17 cases","volume":"110","author":"D\u00edaz","year":"2019","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0038","doi-asserted-by":"crossref","first-page":"e12927","DOI":"10.1111\/dth.12927","article-title":"Cephalosporin-induced linear IgA dermatosis in a child: case report and literature review","volume":"32","author":"Sarikaya Solak","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0039","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bjd.14629","article-title":"Clinical and immunological features and outcome of anti-p200 pemphigoid","volume":"175","author":"Commin","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0041","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-019-1089-2","article-title":"Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients","volume":"14","author":"Genovese","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0042","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00128071-200708060-00010","article-title":"Chronic bullous disease of childhood in a patient with acute lymphoblastic leukemia: possible induction by a drug","volume":"8","author":"Polat","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0043","first-page":"adv00070","article-title":"Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD-1 denoted as a major auto-antigen of the lamina lucida subtype","volume":"100","author":"Cozzani","year":"2020","journal-title":"Acta Derm Venereol"},{"year":"2018","series-title":"Dermatology","author":"Bolognia","key":"10.1016\/j.clindermatol.2021.12.012_bib0044"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","article-title":"Linear IgA bullous dermatosis","volume":"19","author":"Guide","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0046","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.15244","article-title":"Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults","volume":"177","author":"Gottlieb","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0047","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-p200 Pemphigoid: a systematic review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0048","doi-asserted-by":"crossref","first-page":"e41769","DOI":"10.1371\/journal.pone.0041769","article-title":"Pathogenicity of autoantibodies in anti-p200 pemphigoid","volume":"7","author":"Vafia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0049","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2016.1099","article-title":"Laboratory diagnosis and clinical profile of anti-p200 pemphigoid","volume":"152","author":"Meijer","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaad.2019.03.077","article-title":"Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin","volume":"81","author":"Lau","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0051","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0052","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1067\/mjd.2002.120923","article-title":"Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease","volume":"46","author":"Egan","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0053","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5826\/dpc.0604a07","article-title":"IgA pemphigus showing IgA antibodies to desmoglein 1 and 3","volume":"6","author":"Hegazy","year":"2016","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0054","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaad.2015.03.016","article-title":"Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases","volume":"73","author":"Ohata","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00128071-200809010-00006","article-title":"Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review","volume":"9","author":"Bordignon","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0056","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0738-081X(00)00193-0","article-title":"Immunopathology of IgA pemphigus","volume":"19","author":"Hashimoto","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0057","series-title":"Neutrophilic Dermatoses","first-page":"101","article-title":"Superficial neutrophilic dermatoses: from subcorneal pustular dermatosis (Sneddon-Wilkinson Disease) to intercellular IgA dermatoses","author":"Feldmeyer","year":"2018"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0058","first-page":"215","article-title":"Clinicopathologic retrospective analysis of annular pustular psoriasis","volume":"27","author":"Owczarczyk-Saczonek","year":"2018","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0059","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1470.2002.00026.x","article-title":"Annular pustular psoriasis\u2013most common form of pustular psoriasis in children: report of three cases and review of the literature","volume":"19","author":"Liao","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1468-3083.2003.00715.x","article-title":"Erythema annulare centrifugum-type psoriasis: a particular variant of acute-eruptive psoriasis","volume":"17","author":"Vocks","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0061","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1439-0507.2004.01027.x","article-title":"Bullous tinea pedis in two children","volume":"47","author":"Neri","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0062","unstructured":"Centers for Disease Control and Prevention. Hygiene-related diseases: athlete's foot (tinea pedis). Available at: https:\/\/www.cdc.gov\/healthywater\/hygiene\/disease\/athletes_foot.html. Accessed: December 14, 2020."},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0063","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.12.012_bib0064","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21002704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21002704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:46Z","timestamp":1760034046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21002704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0738081X21002704"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.12.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annular bullous diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}